The influence of interleukin-10 and interleukin-18 on interferon-gamma production by peritoneal exudate cells in patients with gastric carcinoma

Anticancer Research

Volumn 22, Issue 2 B, 2002, Pages 1193-1199

  Majima, Takashi ^a   Ichikura, Takashi ^a   Seki, Shuhji ^a   Takayama, Eiji ^a   Matsumoto, Atsushi ^a   Kawabata, Toshinobu ^a   Chochi, Kentaro ^a   Hiraide, Hoshio ^a   Mochizuki, Hidetaka ^a  

^a NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

Author keywords

Gastric carcinoma; IFN ; IL 10; IL 18; Peritoneal exudate cell

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 18; MONOCLONAL ANTIBODY CD3;

ADULT; AGED; ARTICLE; CANCER MORTALITY; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOKINE PRODUCTION; CYTOKINE RELEASE; FEMALE; HUMAN; HUMAN CELL; IMMUNE STATUS; MAJOR CLINICAL STUDY; MALE; PERITONEAL EXUDATE CELL; PRIORITY JOURNAL; PROTEIN DETERMINATION; STOMACH CARCINOMA; SURVIVAL RATE; SURVIVAL TIME; TUMOR GROWTH;

ADULT; AGED; AGED, 80 AND OVER; EXUDATES AND TRANSUDATES; FEMALE; HUMANS; INTERFERON TYPE II; INTERLEUKIN-10; INTERLEUKIN-18; KILLER CELLS, NATURAL; MALE; MIDDLE AGED; NEOPLASM STAGING; PERITONEAL CAVITY; STOMACH NEOPLASMS; SURVIVAL RATE; T-LYMPHOCYTES;

EID: 0036330341     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Th2 subset dominance among peripheral blood T lymphocytes in patients with digestive cancers
2. Interleukin-10 production by human carcinoma cell lines and its relationship to interleukin-6 expression
3. Identification of an IL-10-producing HLA-DR-negative monocyte subset in the malignant ascites of patients with ovarian carcinoma that inhibits cytokine protein expression and proliferation of autologous T cells
4. Modulation of interleukin-18 expression in human colon carcinoma: Consequences for tumor immune surveillance
5. The liver as a crucial organ in the first line of host defense: The roles of Kupffer cells, natural killer (NK) cells and NK 1. 1 Ag+ T cells in T helper I immune responses
6. Cytotoxic gammadelta or alphabeta T cells with a natural killer cell marker, CD56, induced from human peripheral blood lymphocytes by a combination of IL-12 and IL-2
7. Mouse CD8+ CD122+ T cells with intermediate TCR increasing with age provide a source of early IFN-gamma production
8. Decrease of CD56(+)T cells and natural killer cells in cirrhotic livers with hepatitis C may be involved in their susceptibility to hepatocellular carcinoma
9. Regulation of interferon-gamma production by IL-12 and IL-18
10. Essential role for natural killer cells in the lethal lipopolysaccharide-induced Shwartzman-like reaction in mice
11. Liver NK1.1+ CD4+ alpha beta T cells activated by IL-12 as a major effector in inhibition of experimental tumor metastasis
12. Perforin-dependent NK cell cytotoxicity is sufficient for anti-metastatic effect of IL-12
13. Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes
14. Cytotoxic NK1.1 Ag+ alpha beta T cells with intermediate TCR induced in the liver of mice by IL-12
15. Cloning of a new cytokine that induces IFN gamma production by T cells
16. Interferon-gamma-inducing factor enhances T helper 1 cytokine production by stimulated human T cells: Synergism with interleukin-12 for interferon-gamma production
17. IGIF does not drive Thl development but synergizes with IL-12 for interferon-gamma production and activates IRAK and NFkappaB
18. Overview of interleukin-18: More than an interferon-gamma inducing factor
19. + T cells on experimental haernatogenous tumour metastases in the liver and lungs of mice
20. Interleukin 10 pretreatment protects target cells from tumor- and allo-specific cytotoxic T cells and downregulates HLA class I expression
21. Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class 11 major histocompatibility complex expression
22. Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: An autoregulatory role of IL-10 produced by monocytes
23. Macrophage deactivation by interleukin 10
24. IL-10 inhibits cytokine production by activated macrophages
25. Direct effects of IL-10 on subsets of human CD4+ T cell clones and resting T cells. Specific inhibition of IL-2 production and proliferation
26. Immunoregulatory effects of CD4+ T helper subsets in human melanoma
27. Serum interleukin-10 levels in patients with advanced gastrointestinal malignancies
28. Serum interleukin-10 in non-Hodgkin's lymphoma: A prognostic factor
29. Elevated serum levels of interleukin-10 in patients with metastatic malignant melanoma
30. Differential antitumor effects of administration of recombinant IL-18 or recombinant IL-12 are mediated primarily by Fas-Fas ligand- and perforin-induced tumor apoptosis, respectively
31. IL-18 is a potent coinducer of IL-13 in NK and T cells: A new potential role for IL-18 in modulating the immune response
32. In vivo administration of IL-18 can induce IgE production through Th2 cytokine induction and up-regulation of CD40 ligand (CD154) expression on CD4+ T cells
33. IL-18 induction of IgE: Dependence on CD4+ T-cells, IL-4 and STAT6
34. Antitumor and antimetastatic activity of interleukin 12 against murine tumors
35. Protective effect of NK1. 1 (+) T-cells as well as NK-cells against intraperitoneal tumors in mice
36. Origin of CD57+ T-cells which increase at tumour sites in patients with colorectal cancer